Clinical Trial Update: A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Curcuvail in fatty liver disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Curcuvail

Snippet

Sponsor: COD Research Private Ltd | Conditions: Fatty Liver Without Mention of Alcohol | Phase 2 | Status: COMPLETED